Y-27632 Apexbio

Y-27632
B1293-10 10 mg
EUR 142
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Apexbio Reagents Laboratories manufactures the y-27632 apexbio reagents distributed by Genprice. The Y-27632 Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other Y-27632 products are available in stock. Specificity: Y-27632 Category: Apexbio

Y-320
10 mg
EUR 234
Description: Y-320 is a new phenylpyrazoleanilide immunomodulator [1]. Immunotherapy refers to treatment of disease by suppressing, inducing or enhancing an immune response. Y-320 is a new phenylpyrazoleanilide immunomodulator.

Y-320
2 mg
EUR 128
Description: Y-320 is a new phenylpyrazoleanilide immunomodulator [1]. Immunotherapy refers to treatment of disease by suppressing, inducing or enhancing an immune response. Y-320 is a new phenylpyrazoleanilide immunomodulator.

Y-320
10 mM (in 1mL DMSO)
EUR 177
Description: Y-320 is a new phenylpyrazoleanilide immunomodulator [1]. Immunotherapy refers to treatment of disease by suppressing, inducing or enhancing an immune response. Y-320 is a new phenylpyrazoleanilide immunomodulator.

Y 11
10 mg
EUR 221

Y 11
25 mg
EUR 415

Y 11
5 mg
EUR 147

Y-26763
5 mg
EUR 196

Human Samples information

Y 134
B7149-10 10 mg
EUR 373

Y 134
B7149-50 50 mg
EUR 1363

Y-320
B3425-10 10 mg
EUR 234
Description: Y-320 is a new phenylpyrazoleanilide immunomodulator [1]. Immunotherapy refers to treatment of disease by suppressing, inducing or enhancing an immune response. Y-320 is a new phenylpyrazoleanilide immunomodulator.

Y-320
B3425-2 2 mg
EUR 128
Description: Y-320 is a new phenylpyrazoleanilide immunomodulator [1]. Immunotherapy refers to treatment of disease by suppressing, inducing or enhancing an immune response. Y-320 is a new phenylpyrazoleanilide immunomodulator.

Y-320
B3425-5.1 10 mM (in 1mL DMSO)
EUR 177
Description: Y-320 is a new phenylpyrazoleanilide immunomodulator [1]. Immunotherapy refers to treatment of disease by suppressing, inducing or enhancing an immune response. Y-320 is a new phenylpyrazoleanilide immunomodulator.

Y 11
B5621-10 10 mg
EUR 221

Y 11
B5621-25 25 mg
EUR 415

Y 11
B5621-5 5 mg
EUR 147

Y-26763
B6939-5 5 mg
EUR 196

Y-27152
B6940-10 10 mg
EUR 389

Y-27152
B6940-50 50 mg
EUR 1476

Neuropeptide Y (scrambled)
B7530-1 1 mg
EUR 405
Description: Scrambled Neuropeptide Y (scNPY) was similarly synthesized and contains the same amino acids as NPY, but scNPY is in a random sequence, it was used as a control in the research in NPY [1]. The sequence of scNPY is SKPQRDANREPTRYAIYDYSNPDIELHYLRPAYALG-NH2 [2].

Y-29794 oxalate
B5153-10 10 mg
EUR 366

Y-29794 oxalate
B5153-50 50 mg
EUR 1379

740 Y-P
B5246-1 1 mg
EUR 166
Description: 740 Y-P is an activator of PI3K with concentration of 20 ?M [1]. PI3K (phosphoinositide 3-kinases, PI3Ks) is an enzyme and plays an important role in the fundamental cellular processes, such as vesicular trafficking, cell degranulation, cell migration, and glucose transporter.

740 Y-P
B5246-5 5 mg
EUR 340
Description: 740 Y-P is an activator of PI3K with concentration of 20 ?M [1]. PI3K (phosphoinositide 3-kinases, PI3Ks) is an enzyme and plays an important role in the fundamental cellular processes, such as vesicular trafficking, cell degranulation, cell migration, and glucose transporter.

Y-39983 dihydrochloride
B1176-10 10 mg
EUR 412
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].